Erlotinib Completed Phase 2 Trials for Cholangiocarcinomas / Gallbladder Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00350753Avastin and Tarceva for Upper Gastrointestinal Cancers